Molecular epidemiology of Escherichia coli mediated urinary tract infections

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Zhang, Lixin ^a,b   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b Department of Epidemiology ^*  (United States)

Author keywords

Escherichia coli; Review; Urinary Tract Infection; Virulence Factors

Indexed keywords

ADHESIN; AMPICILLIN; ANTIBIOTIC AGENT; CELL RECEPTOR; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOTOXIC NECROTIZING FACTOR 1; ESCHERICHIA COLI VACCINE; FIMH ADHESIN; HEMOLYSIN; NITROFURANTOIN; PROBIOTIC AGENT; SIDEROPHORE; TOXIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANATOMY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BEHAVIOR; CELL POPULATION; CLINICAL FEATURE; CLINICAL TRIAL; COLON; CONTRACEPTION; ENTEROBACTER INFECTION; ESCHERICHIA COLI; GENETIC SUSCEPTIBILITY; HOST; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; INFLAMMATION; LACTOBACILLUS; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; PATHOGENESIS; PATHOGENICITY ISLAND; PHYLOGENY; POPULATION STRUCTURE; RECURRENT INFECTION; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; SYMPTOM; URETHRA; URINARY TRACT INFECTION; VAGINA;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; LACTOBACILLUS;

EID: 3142677329     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. JW Warren: Clinical presentations and epidemiology of urinary tract infections. In: Urinary tract infections: molecular pathogenesis and clinical management. Eds: Harry L T, Warren J W, ASM press, Washington D. C. (1996)
2. Zielske J.V., K.N. Lohr, R.H. Brook & G.A. Goldberg: Conceptualization and measurement of physiologic health for adults. Urinary tract infection [report]. The Rand Corporation; R2262/16-HHS. (1981)
3. Foxman B., R. Barlow, H. d'Arcy, B. Gillespie & J.D. Sobel: Urinary tract infection: estimated incidence and associated costs. J Clin Epidemiol 10, 509-515 (2000)
4. Foxman B: Recurring urinary tract infections: incidence and risk factors. Am J Public Health 80, 331-333 (1990)
5. Stamm W.E., T.M. Hooton, J.R. Johnson, C. Johnson, A. Stapleton, P.L. Roberts, S.L. Moseley & S.D. Fihn: Urinary tract infections: from pathogenesis to treatment. J Infect Dis 159, 400-406 (1989)
6. Johnson J.R. & W.E. Stamm: Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 111, 906-917 (1989)
7. Kunin C.M: Urinary tract infections: Detection, Prevention, and Management. Fifth Edition. Baltimore: Williams & Wilkins. (1997)
8. Stamm W.E: Recent developments in the diagnosis and treatment of urinary tract infections. Western J Med 137, 213-20 (1982)
9. Kass E.H: Afterthought to the symposium on pyelonephritis. In: Biology of pyelonephritis. Eds: Quinn E.L., Kass E.H., Boston: Little, Brown page 694-695 (1959)
10. Schaeffer A.J.: Classification of urinary tract infection in adults. In: Harnwegsinfektion: Pathogenetische, Klinische und therapeutische Aspekte. Eds: Funfstuck R, Straube E, Stein G, Lengerich, Pabst Science Publishers, 140-147 (1997)
11. Foxman B., J. Marsh, B. Gillespie, N. Rubin, J. S. Koopman & S. Spear: Condom use and first-time urinary tract infection. Epidemiol 8, 637-641 (1997)
12. Buckley R. M., M. McGuckin & R. R. MacGregor: Urine bacterial counts after sexual intercourse. N Engl J Med 298, 321-324 (1978)
13. Nicolle L.E., G.K.M. Harding, J. Preiksaitis & A.R. Ronald: The association of urinary tract infection with sexual intercourse. J Infect Dis 146, 579-583 (1982)
14. Fihn S.D., E.J. Boyko, E.H. Normand, C.L. Chen, J.R. Grafton, M. Hunt, P. Yarbro, D. Scholes & A. Stergachis: Association between use of spermicide-coated condoms and Escherichia coli urinary tract infection in young women. Amer J of Epid 144, 512-20 (1996)
15. Foxman B. & R. R. Frerichs: Epidemiology of urinary tract infection. J Clin Epidemiol 43, 329-337 (1985)
16. Hooton T.M., D. Scholes, J.P. Hughes, C. Winter, P.L. Robert, A.E. Stapleton, A. Stergachis & W.E. Stamm: A prospective study of risk factors for symptomatic urinary tract infection in young adults. N Engl J Med 335, 468-474 (1996)
17. Foxman B., A. M. Geiger, K. Palin, B. Gillespie & J. S. Koopman: First-time urinary tract infection and sexual behavior. Epidemiol 6, 162-168 (1995)
18. Foxman B., L. Zhang, P. Tallman, B.C. Andree, A.M. Geiger, J.S. Koopman, B.W. Gillespie, K.A. Palin, J.D. Sobel, C.K. Rode, C.A. Bloch & C. F. Marrs: Transmission of uropathogens between sex partners. J Infect Dis 175:989-992 (1997)
19. Scholes D., T.M. Hooton, P.L. Roberts, K. Gupta & W.E. Stamm: Risk factors for recurrent UTI in young women. J Infect Dis 182, 1177-82 (2000)
20. Schaeffer A.J: What do we know about the urinary tract infection-prone individual? J Infect Dis 183(Suppl 1), S66-9 (2001)
21. Foxman B., L. Zhang, K. Palin, P. Tallman & C. F. Marrs: Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. J Infect Dis 171, 1514-1521 (1995)
22. Strom B.L., M. Collins, S.L. West, J. Kreisberg & S. Weller: Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria. Ann Intern Med 107, 816-823 (1987)
23. Stromberg N., B.I. Marklund, B. Lund, D. Ilver, A. Hamers, W. Gaastra, K.A. Karlsson & S. Normark: Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors. EMBO J 9, 2001-2010 (1990)
24. Plos K., H. Connell, U. Jodal, B.I. Marklund, S. Marild, B. Wettergren & C. Svanborg: Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 171, 625-31 (1995)
25. Agace W., H. Connell & C. Svanborg: Host resistance to urinary tract infection. In: Urinary tract infection: Molecular pathogenesis and clinical management. Eds: Mobley HLT, Warren JW, American Society for Microbiology, Washington, DC 221-243 (1996)
26. Stapleton A., E. Nudelman, H. Clausen, S. Hakomori & W.E. Stamm: Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 90, 965-72 (1992)
27. O'Grady F., C.L. Ganci and B.W. Watson: In vitro models simulating conditions of bacterial growth in the urinary tract. In: Urinary Tract Infections. Eds: O'Grady F, Brunfitt W, London, Oxford University Press, (1968)
28. Kinane D.F., C.C. Blackwell, R.P. Brettle, D.M Weir, F.P. Winstanley & R.A. Elton. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br Med J 285, 7-9 (1982)
29. Sheinfeld J., A.J. Schaeffer, C. Cordon-Cardo, A. Rogatko & W.R. Fair: Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. New Engl J Med 320, 773-7 (1989)
30. Agace W., S. Hedges, U. Andersson, J. Andersson, M. Ceska & C. Svanborg: Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun 61, 602-9 (1993)
31. Hooton T.M., A.E. Stapleton, P.L. Roberts, C. Winter, D. Scholes, T. Bavendam & W.E Stamm: Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin Infect Dis 29, 1600-16001 (1999)
32. Kunin C.M. & R.C. McCormack: An epidemiologic study of bacteriuria and blood pressure among nuns and working women. New Engl J Med 278, 635-642 (1968)
33. Metcalf P.A., J.R. Baker, P.K.R. Scragg, A. Scott, C.J. Wild & E. Dryson: Asymptomatic bacteriuria in a multiracial workforce. Ethnicity Dis 3, 270-277 (1993)
34. th edition. Appleton-Century-Crofts, Inc. 1968
35. Foxman B., S. Manning, P. Tallman, R. Bauer, L. Zhang, J. Koopman, B. Gillespie, J.D. Sobel, & C.F. Marrs: Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. Am J Epidemiol (In press) (2002)
36. Ikaheimo R., A. Siitonen, T. Heiskanen, U. Karkkainen, P. Kuosmanen, P. Lipponen & P.H. Makela: Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 22, 91-99 (1996)
37. Mulvey M.A., J.D. Schilling & S.J. Hultgren: Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69:4572-4579 (2001)
38. Kunin C.M., F. Polyak & E. Postel: Periurethral bacterial flora in women. Prolonged intermittent colonization with Escherichia coli. JAMA. 243, 134-9 (1980)
39. Smith H.S., J. P. Hughes, T.M. Hooton, P.L. Roberts, D. Scholes, A. Stergachis, A. Stapleton, W.E. Stamm: Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis 25, 63-8 (1997)
40. Orskov I., F. Orskov, B. Jann & K. Jann: Serology, chemistry and genetics of O and K antigens of Escherichia coli. Bac Rev 41, 667-710 (1977)
41. Staley J. T: Bacterial biodiversity: a time for place. ASM News 65, 681-687 (1999)
42. Bergthorsson U. & H. Ochman: Distribution of chromosome length variation in natural isolates of Escherichia coli. Mol Biol Evol 15, 6-16 (1998)
43. Caugant D.A., B.R. Levin, G. Lidin-Janson, T.S. Whittam, C. Svanborg Eden & R.K. Selander: Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections. Prog Allergy 33, 203-207 (1983)
44. Marrs C.F., L. Zhang, P. Tallman, S. Manning, P. Somsel, R. Raz, R. Colodner, M.E. Jantunen, A. Siitonen, H. Saxen & B. Foxman: Escherichia coli virulence gene distributions show interesting differences between urinary tract infection, fecal and periurethral isolate collections. J Med Microbiol 51, 138-142 (2002)
45. Caugant D.A., B. R. Levin & R. K. Selander: Genetic diversity and temporal variation in the Escherichia coli population of a human host. Genetics 98, 467-490 (1981)
46. Souza V., T. T. Nguyen, R. R. Hudson, D. Pinero & R. E. Lenski: Hierarchical analysis of linkage disequilibrium in Rhizobium populations: evidence for sex? Proc Natl Acad Sci USA 89, 8389-8393 (1992)
47. Whittam T. S., H. Ochman & R. K. Selander: Geographic components of linkage disequilibrium in natural populations of Escherichia coli. Mol Biol Evol 1, 67-83 (1983)
48. Herzer P. J., S. Inouye, M. Inouye & T.S. Whittam: Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 172, 6175-6181 (1990)
49. Caugant D. A., B. R. Levin, I. Orskov, F. Orskov, C. Svanborg Eden & R. K. Selander: Genetic diversity in relation to serotype in Escherichia coli. Infect Immun 49, 407-413 (1985).
50. Bingen E., B. Picard, N. Brahimi, S. Mathy, P. Desjardins, J. Elion & E. Denamur: Phylogenetic analysis of Escherichia coli strains causing neonatal meningitis suggests horizontal gene transfer from a predominant pool of highly virulent B2 group strains. J Infect Dis 177, 642-650 (1998)
51. Body E. F., & D. L. Hartl: Chromosomal regions specific to pathogenic isolates of Escherichia coli have a phylogenetically clustered distribution. J Bacteriol 180, 1159-1165 (1998)
52. Johnson J. R & A. L. Stell: Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181, 261-72 (2000)
53. Picard B., J. S. Garcia, S. Gouriou, P. Duriez, N. Brahimi, E. Bingen, J. Elion & E. Denamur: The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67, 546-553 (1999)
54. Duriez P., O. Clermont, S. Bonacorsi, E. Bingen, A. Chaventre, J. Elion, B. Picard & E. Denamur: Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiol 147, 1671-1676 (2001)
55. Zhang L., B. Foxman & C.F. Marrs: Both urinary and rectal Escherichia coli isolates are dominated by strains of phylogenetic group B2. J Clin Microbiol (In press) (2002)
56. Picard B., N. Picard-Pasquier, R. Krishnamoorthy & P. Goullet: Characterization of highly virulent Escherichia coli strains by ribosomal DNA restriction fragment length polymorphism. FEMS Microbiol Lett 82, 183-188 (1987)
57. Pupo G. M., D. K. R. Karaolis, R. Lan & P. R. Reeves: Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies. Infect Immun 65, 2685-2692 (1997)
58. Donnenberg M.S. & R. S. Welch: Virulence determinants of uropathogenic Escherichia coli. In: Urinary tract infections: molecular pathogenesis and clinical management. Eds: Harry L.T., J. W. Warren, ASM press, Washington D. C. (1996)
59. Johnson J. R: Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4, 80-128 (1991)
60. Mobley H.L.T., M.D. Island & G. Massad: Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Kidney Int Suppl 47, 129-136 (1994)
61. Foxman B., L. Zhang, P. Tallman, K. Palin, C. Rode, C. Bloch, B. Gillespie & C. F. Marrs: Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J Infect Dis 172, 1536-1541 (1995)
62. Yamamoto S., T. Tsukamoto, A Terai, H. Kurazono, Y. Takeda & O. Yoshida: Distribution of virulence factors in Escherichia coli isolated from urine of cystitis patients. Microbiol Immunol 39, 401-404 (1995)
63. Aronson M., Q. Medalia, L. Schori, D. Mirelman, N. Sharon & I. Ofek: Prevention of colonisation of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl-D-manno-pyranoside. J Infect Dis 139, 329 (1979)
64. Connell I., W. Agace, P. Klemm, M. Schembri, S. Marild & C. Svanborg: Type 1 fimbrial adhesion enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 93, 731-740 (1996)
65. Hagberg L., R. Hull, S. Hull, S. Falkow, R. Freter & C. Svanborg Eden: Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun 40, 265-272 (1983)
66. Sokurenko E.V., V. Chesnokova, R.J. Doyle & D.L. Hasty: Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J Bio Chem 272, 17880-178866 (1997)
67. Schaeffer A.J., M.F. Venegas, R.A. Gaffney, E.L. Navas, B.E. Anderson, J.S. Chmiel & J.L. Duncan: Role of vaginal fluid in urinary tract infections (UTIs). Proc Natl Acad Sci USA 155, 647A (1996)
68. Manning S.D, L. Zhang, B. Foxman, A Spindler, P. Tallman & C.F. Marrs: The Prevalence of known P-fimbrial G-alleles in Escherichia coli and the Determination of a New Adhesin Class. Clin Diag Lab Immun 8, 637-640 (2001)
69. Korhonen T.K., V. Vaisanen-Rhen, M. Rhen, A. Pere, J. Parkkinen & J. Finne: Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol 159, 762-766 (1984)
70. Marre R., J. Hacker, W. Henkel & W. Goebel: Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun 54, 761-767 (1986)
71. Nowicki B., A. Hart, K.E. Coyne, D.M. Lublin & S. Nowicki: Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med 178, 2115-2121 (1993)
72. Archambaud M., P. Courcoux & A. Labigne-Roussel: Detection by molecular hybridization of pap, afa, and sfa adherence systems in Escherichia coli strains associated with urinary and enterai infections. Ann Inst Pasteur Microbiol 139, 557-573 (1988)
73. Arthur M., C.E. Johnson, R.H. Rubin, R.D. Arbeit, C. Campanelli, C. Kim, S. Steinbach, M. Agarwal, R. Wilkinson & R. Goldstein: Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun 57, 303-313 (1989)
74. Daigle F., J. Harel, J.M. Fairbrother & P Lebel: Expression and detection of pap-, sfa-, and afa-encoded fimbrial adhesin systems among uropathogenic Escherichia coli. Can J Microbiol 40, 286-291 (1994)
75. Goluszko P., D. Niesel, B. Nowicki, R. Selvarangan, S. Nowicki, A. Hart, E. Pawelczyk, P. Das M. Urvil & R. Hasan: Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis. Infect Immun 69, 4678-4680 (2001)
76. Ikaheimo R., A. Siitonen, U. Karkkainen, P. Kuosmanen & P.H. Makela: Characteristics of Escherichia coli in acute community-acquired cystitis of adult women. Scand J Infect Dis 25, 705-712 (1993)
77. Caprioli A., V. Falbo, R.M. Ruggeri, L. Baldassarri, R. Bisicchia, G. Ippolito, E. Romoli & G. Donelli: Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol 25, 146-149 (1987)
78. th General Meeting of the American Society for Microbiology, 55, (1997)
79. Guyer D.M., I.R. Henderson, J.P. Nataro & H.L. Mobley: Identification of sat, an autotransporter toxin produced by uropathogenic Escherichia coli. Mol Microbiol 38, 53-66 (2000)
80. Guyer D.M., S. Radulovic, F.E. Jones & H.L. Mobley: Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 70, 4539-46 (2002)
81. Montgomerie J.Z., A. Bindereif, J.B. Neilands, G.M. Kalmanson & L.B. Guze: Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteremia. Infect Immun 46, 835-838 (1984)
82. Carbonetti N.H., S. Boonchai, S.H. Parry, V. Vaisanen-Rhen, T.K. Kornonen & P.H. Williams: Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections. Infect Immun 51, 966-968 (1986)
83. Russo T.A., U.B. Carlino, A. Mong & S.T. Jodush: Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine. Infect Immun 67, 5306-14 (1999)
84. E. coli. J Infect Dis 185, 1521-1524 (2002)
85. Johnson J.R., T.A. Russo, P.I. Tarr, U. Carlino, S.S. Bilge, J.C. Jr. Vary & A.L. Stell: Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN (E. coli), among Escherichia coli isolates from patients with urosepsis. Infect Immun 68, 3040-7 (2000)
86. Lundrigan M.D. & R.M. Webb Prevalence of ompT among Escherichia coli isolates of human origin. FEMS Microbiol Le 76, 51-6 (1992)
87. Zhang L., B. Foxman, P. Tallman, E. Cladera, C. Bouguenec & C. F. Marrs: Distribution of drb genes coding for Dr binding adhesins among uropathogenic and fecal Escherichia coli isolates and identification of new subtypes. Infect Immun 65:2011-2018 (1997)
88. Hacker J., G. Blum-Oehler, I. Muhldorfer & H. Tschape: Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 23, 1089-1097 (1997)
89. Lee C.A: Pathogenicity islands and the evolution of bacterial pathogens. Infect Agents Dis 5, 1-7 (1996)
90. Goullet P. & B. Picard: Highly pathogenic strains of Escherichia coli revealed by the electrophoretic patterns of carboxylesterase. B J Gen Microbiol 132, 1853-1858 (1986)
91. Hooton T.M. & W.E. Stamm: Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis Clin N Am 11, 551-581 (1997).
92. Gupta K., D. Scholes & W.E. Stamm: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 281, 736-738 (1999)
93. Brown P.D., A. Freeman & B. Foxman: Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Michigan. Clin Infect Dis (in press) (2002)
94. Kahlmeter G: The ECO•SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens - interim report. J Antimicrob Chemother 46(Suppl. S1), 15-22 (2000)
95. Hart A., B.J. Nowicki, B. Reisner, E. Pawelczyk, P. Goluszko, P. Urvil, G. Anderson & S. Nowicki: Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 15, 1526-1529 (2001)
96. Avorn J., M. Monane, J.H. Gurwitz, R.J. Glynn, I. Choodnovskiy & L.A. Lipsitz: Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 271, 751 (1994)
97. Ahuja S., B. Kaack & J. Roberts: Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 159, 559-562 (1998)
98. Triezenberg D.J: Can regular intake of either cranberry juice or a drink containing Lactobacillus bacteria prevent urinary tract infection (UTI) recurrence in women after an initial episode? J Fam Pract 50, 841 (2001)
99. Foxman B., P. Somsel, P. Tallman, B. Gillespie, R. Raz, R. Colodner, D. Kandula & J.D. Sobel: Urinary tract infection among women aged 40 to 65: behavioral and sexual risk factors. J Clin Epid 54, 710-8 (2001)
100. Kontiokari T., K. Sundqvist, M. Nuutinen, T. Pokka, M. Koskela & M. Uhari: Randomized trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. Br Med J 2001, 322:1-5 (2001)
101. Reid G & J. Burton: Use of lactobacillus to prevent infection by pathogenic bacteria. Micro & Infect 4:319-324 (2002)
102. Uehling D.T., W.J. Hopkins, E. Balish, Y. Xing & D.M. Heisey: Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol 157, 2049-52 (1997)
103. Roberts J.A., M.B. Kaack, G. Baskin, T.K. Korhonen, S.B. Svenson & J. Winberg: P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis. Pediatr Nephrol 3, 391-6 (1989)
104. Langermann S., S. Palaszynski, M. Barnhart, G. Auguste, J.S. Pinkner, J. Burlein, P. Barren, S. Koenig, L. Leath, C.H. Jones & S. Hultgren: Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 276, 697 (1997)
105. Thankavel K., B. Madison, T. Ikeda, R. Malaviya, A.H. Sham, P.M. Arumugam & S.N. Abraham: Localization of a domain in the FimH adhesin of Escherichia coli Type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. J Clin Invest 100, 1123 (1997)
106. Zhang L., B. Foxman, S. Manning, P. Tallman & C.F. Marrs: Molecular epidemiologic approaches to UTI gene discovery in uropathogenic Escherichia coli. Infect Immun 68, 2009-2015 (2000)
107. Clarke S. C: Diarrhoeagenic Escherichia coli - an emerging problem Diagn Microbiol Infect Dis 41, 93-98 (2001)
108. Nataro J.P. & J.B. Kaper: Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201 (1998)